DYAI

Dyadic International, Inc. is a leading biotechnology platform company based in Jupiter, Florida, specializing in the development and production of enzymes and recombinant proteins tailored for diverse applications within the life sciences sector. Utilizing its proprietary C1 cell protein production platform, Dyadic enhances the efficiency and cost-effectiveness of biopharmaceutical manufacturing, catering to the increasing global demand for biologics such as therapeutic proteins and vaccines. The company is committed to driving innovation through strategic partnerships and collaborations, positioning itself as a key player in advancing biomanufacturing technologies and contributing to the future of health and medicine.